Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Solute carrier family 22 member 6 (SLC22A6), commonly known as Organic anion transporter 1 (OAT1), is a transmembrane protein primarily expressed in the basolateral membrane of renal proximal tubule cells (UniProt: P48431). It functions as an organic anion/dicarboxylate exchanger, facilitating the uptake of substrates from the blood into the kidney for subsequent secretion into the urine (PubMed: 23506833). This transporter is essential for the renal clearance of numerous endogenous metabolites and exogenous compounds, including antibiotics, antivirals, and NSAIDs (NIH: Gene ID 9356). Because it handles a wide range of substrates, it is a primary site for clinically significant drug-drug interactions; for instance, probenecid is often used to inhibit OAT1 to reduce the nephrotoxicity of cidofovir or to increase the plasma concentration of penicillins (StatPearls: Probenecid). Genetic variations in the SLC22A6 gene can significantly impact an individual's drug response and susceptibility to toxin-induced kidney damage. Beyond pharmacology, SLC22A6 is involved in the transport of signaling molecules like prostaglandins and metabolic intermediates like alpha-ketoglutarate, linking it to metabolic homeostasis and conditions like hyperuricemia (Wikipedia: SLC22A6). Overall, SLC22A6 is a critical target for understanding pharmacokinetics and ensuring drug safety in clinical development.
Competitive inhibition of organic anion transport
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 22 member 6 (Organic anion transporter 1) (SLC22A6).